
The United States Department of Justice is suing to block UnitedHealth Group's $3.3 billion acquisition of Amedisys, arguing that it would harm competition.
The DOJ claims that the deal, which values Amedisys at $101 a share, would give UnitedHealth excessive control over healthcare services, according to the Wall Street Journal.